Novo Integrated Sciences, Inc.
NVOSOTCHealthcare● Active
$0.01
$-0.01(-55.00%)
Market Cap$177572
P/E Ratio—
52W High$0.06
52W Low$0.0001
Novo Integrated Sciences, Inc. (NVOS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVOS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-08 | 2023-08 | 2022-08 | 2021-08 | 2020-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $13.29M | $12.57M | $11.74M | $9.31M | $7.86M |
| Cost of Revenue | $7.55M | $7.62M | $6.94M | $5.48M | $4.80M |
| Gross Profit | $5.74M | $4.95M | $4.80M | $3.82M | $3.06M |
| Gross Margin %(computed) | 43.20% | 39.39% | 40.89% | 41.08% | 38.91% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $14.04M | $13.49M | $14.36M | $8.09M | $7.29M |
| Total Operating Expenses | $14.06M | $13.51M | $14.39M | $8.20M | $7.29M |
| Operating Income | ($8.31M) | ($8.55M) | ($9.59M) | ($4.27M) | ($4.26M) |
| Operating Margin %(computed) | -62.54% | -68.03% | -81.67% | -45.93% | -54.23% |
| Interest Income | $0.20M | $0.01M | $0.17M | $0.05M | $0.03M |
| Interest Expense | ($0.65M) | $5.12M | $7.57M | $0.17M | $0.16M |
| Income Before Tax | ($16.13M) | ($13.27M) | ($33.07M) | ($4.47M) | ($4.92M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.02M) | $0.00M | $0.00M |
| Net Income | ($16.13M) | ($13.21M) | ($32.85M) | ($4.46M) | ($4.92M) |
| Net Margin %(computed) | -121.32% | -105.11% | -279.86% | -47.95% | -62.53% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.90 | $-1.30 | $-11.28 | $-1.80 | $-2.13 |
| Wtd Avg Shares | 18.03M | 10.17M | 2.91M | 2.48M | 2.30M |
| EBITDA | ($10.08M) | ($5.85M) | ($22.48M) | ($2.58M) | ($2.78M) |
| EBITDA Margin %(computed) | -75.79% | -46.52% | -191.52% | -27.75% | -35.38% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Novo Integrated Sciences, Inc. data
About Novo Integrated Sciences, Inc. (NVOS) Income Statement
Novo Integrated Sciences, Inc. (NVOS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, NVOS reported revenue of $0.01B, gross profit of $0.01B (gross margin 43.20%), and net income of ($0.02B) — a net profit margin of -121.32%.
Frequently asked questions
NVOS · 4 questionsNovo Integrated Sciences, Inc. (NVOS) reported revenue of $0.01B for 2024, up 5.7% year-over-year.
NVOS revenueNVOS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09